World Journal of Endocrine Surgery

Register      Login

VOLUME 3 , ISSUE 2 ( May-August, 2011 ) > List of Articles


Long-term Results after Total Thyroidectomy in Patients with Graves' Disease in Uzbekistan: Retrospective Study

Said I Ismailov, Nusrat A Alimjanov, Bakhodir Kh Babakhanov, Murod M Rashitov, Alisher M Akbutaev

Citation Information : Ismailov SI, Alimjanov NA, Babakhanov BK, Rashitov MM, Akbutaev AM. Long-term Results after Total Thyroidectomy in Patients with Graves' Disease in Uzbekistan: Retrospective Study. World J Endoc Surg 2011; 3 (2):79-82.

DOI: 10.5005/jp-journals-10002-1062

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2011; The Author(s).


Subtotal thyroidectomy has been advocated as the standard treatment for Graves' disease (GD) because of the assumed lower risk of complications compared with total thyroidectomy, and also it provides the chance to avoid thyroxin therapy. The present study aims to examine our institutional experience with total thyroidectomy for GD. Patients were divided into two surgical treatment groups: Total thyroidectomy (TT) (n = 97) and total thyroidectomy with intraoperative thyroid autotransplantation (TTITA) (n = 74). TTITA performed in 74 patients. 0.5 to 2 gm of thyroid tissue was cut into small pieces and autotransplanted into the forearm muscle of the patient. Postoperative complications included eight cases of RLN palsy, two patients had nerve paralysis, two patients underwent tracheostomy, transient hypoparathyroidism in 25 patients, permanent hypoparathyroidism in two cases, wound hemorrhage in two patients. TPOAb levels were increased in 9% of patients with TT whereas in patients with TTITA TPOAb concentrations were elevated in 65% of patients at 3 months follow-up. TRAb in patients with TT were not detected while 20% patients undergone TTITA had high TRAb levels and 13.3% had terminal concentrations at 3 months follow-up. Serum TPOAb and TRAb were detected in none of the patients who underwent TT and TTITA at 1, 3 and 5 years follow-up. Removal of all thyroid tissue offers the best chance of preventing recurrent hyperthyroidism and we saw no increase in postoperative complications in the TT group. We feel that TT is safe and superior for achieving the goal of treatment of Graves' disease.

PDF Share
  1. The spectrum of thyroid disease in a community: The whickham survey. Clin Endocrinol 1977;7:481-93.
  2. Does extralaryngeal branching have an impact on the rate of postoperative transient or permanent recurrent laryngeal nerve palsy? World Journal of Surgery 2009;33(2):261-65.
  3. The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res 2000;90:161-65.
  4. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 2001;25:307-10.
  5. Thyroidectomy for selected patients with hypotoxicosis. Arch Otolaryngol Head Neck Surg 2001;127:61-65.
  6. Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease. ANZ J Surg 2002;72:321-24.
  7. Total thyroidectomy for benign thyroid disease. Laryngoscope 2003;113:1820-26.
  8. Graves’ hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine: A prospective, randomized study. Thyroid study group. J Clin Endocrinol Metab 1996;81:2986-93.
  9. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998;338:712-18.
  10. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-55.
  11. Treatment of Graves’ disease: The advantages of surgery. Endocrinol Metab Clin North Am 2000;29:321-37.
  12. Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves’ disease. Am Coll Surg 2002;194:14-22.
  13. Trial of thyroid autotransplantation in patients with Graves’ disease whose remnant thyroid has unintentionally been made too small at subtotal thyroidectomy. Endocrinol Jpn Feb 1990;37(1):95-101.
  14. Surgical treatment of Graves’ disease in patients younger than 18 years. World J Surg 1996;20:794-800.
  15. Surgery for Graves’ disease—Total versus subtotal thyroidectomy: Results of a prospective randomized trial. World J Surg 2000;24:1303-11.
  16. Preoperative change of thyroid stimulating hormone receptor antibody level: Possible marker for predicting recurrent hyperthyroidism in patients with Graves’ disease after subtotal thyroidectomy. World J Surg 1996;20:801-07.
  17. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves’ disease. ANZ J Surg 2005;75:528-31.
  18. Longterm results after subtotal thyroidectomy with and without intraoperative thyroid autotransplantation in patients with Graves’ disease. Uzb Surg 2009;4:17-20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.